[1]
|
Diabetic Neuropathy
Contemporary Diabetes,
2023
DOI:10.1007/978-3-031-15613-7_15
|
|
|
[2]
|
Diabetic Neuropathy
Contemporary Diabetes,
2023
DOI:10.1007/978-3-031-15613-7_15
|
|
|
[3]
|
Glycyrrhizic acid promotes sciatic nerves recovery in type 1 diabetic rats and protects Schwann cells from high glucose-induced cytotoxicity
The Journal of Biomedical Research,
2022
DOI:10.7555/JBR.36.20210198
|
|
|
[4]
|
Glycyrrhizic acid promotes sciatic nerves recovery in type 1 diabetic rats and protects Schwann cells from high glucose-induced cytotoxicity
The Journal of Biomedical Research,
2022
DOI:10.7555/JBR.36.20210198
|
|
|
[5]
|
12/15-Lipoxygenase Regulation of Diabetic Cognitive Dysfunction Is Determined by Interfering with Inflammation and Cell Apoptosis
International Journal of Molecular Sciences,
2022
DOI:10.3390/ijms23168997
|
|
|
[6]
|
Association of hyperglycaemia with the placenta of GDM-induced macrosomia with normal pre-pregnancy BMI and the proliferation of trophoblast cells
Journal of Obstetrics and Gynaecology,
2022
DOI:10.1080/01443615.2022.2036969
|
|
|
[7]
|
Glycyrrhizic acid promotes sciatic nerves recovery in type 1 diabetic rats and protects Schwann cells from high glucose-induced cytotoxicity
The Journal of Biomedical Research,
2022
DOI:10.7555/JBR.36.20210198
|
|
|
[8]
|
Upregulation of miR-133a-3p in the Sciatic Nerve Contributes to Neuropathic Pain Development
Molecular Neurobiology,
2020
DOI:10.1007/s12035-020-01999-y
|
|
|
[9]
|
Targeting the NADPH Oxidase-4 and Liver X Receptor Pathway Preserves Schwann Cell Integrity in Diabetic Mice
Diabetes,
2020
DOI:10.2337/db19-0517
|
|
|
[10]
|
Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets
European Journal of Pharmacology,
2018
DOI:10.1016/j.ejphar.2018.06.034
|
|
|
[11]
|
Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathy
The FASEB Journal,
2018
DOI:10.1096/fj.201701391R
|
|
|
[12]
|
Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complications
Pharmacology & Therapeutics,
2018
DOI:10.1016/j.pharmthera.2018.10.010
|
|
|
[13]
|
Schwann cell interactions with axons and microvessels in diabetic neuropathy
Nature Reviews Neurology,
2017
DOI:10.1038/nrneurol.2016.201
|
|
|
[14]
|
Inhibitors of Poly(ADP-Ribose)Polymerase-1 as Agents Providing Correction of Brain Dysfunctions Induced by Experimental Diabetes
Neurophysiology,
2017
DOI:10.1007/s11062-017-9672-4
|
|
|
[15]
|
Immunoregulatory effects of vitamin D3 in experimentally induced type 1 diabetes
Cytology and Genetics,
2016
DOI:10.3103/S0095452716040071
|
|
|
[16]
|
Effects of High Glucose on Cell Viability and Differentiation in Primary Cultured Schwann Cells: Potential Role of ERK Signaling Pathway
Neurochemical Research,
2016
DOI:10.1007/s11064-015-1824-6
|
|
|
[17]
|
Synergistic Effects of Combining Anti-Midkine and Hepatocyte Growth Factor Therapies Against Diabetic Nephropathy in Rats
The American Journal of the Medical Sciences,
2015
DOI:10.1097/MAJ.0000000000000510
|
|
|
[18]
|
Effect of High-Fat Diet on Peripheral Neuropathy in C57BL/6 Mice
International Journal of Endocrinology,
2014
DOI:10.1155/2014/305205
|
|
|